Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BARRX signs Japan distribution deal for ablation system

This article was originally published in Clinica

Executive Summary

BARRX Medical is to take its HALO radiofrequency ablation system to the Japanese market after signing an exclusive distribution deal with medical product supply company Medico’s Hirata. The HALO system, which is also FDA-cleared and CE-marked, is designed to treat gastroenterological diseases by removing diseased tissue and allowing the re-growth of new, normal cells. According to Sunnyvale, California-based BARRX, the HALO system “has shown encouraging results in recent clinical trials…in eradicating early oesophageal squamous neoplasia, a precursor to oesophageal cancer”. BARRX said that Japan has one of the highest concentrations of oesophageal squamous cell cancers in the world. Financial terms of the deal were not disclosed.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT095552

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel